People who take weight-loss drugs based on GLP-1 receptor agonists seem to have reduced risk for a litany of diseases, including Alzheimer's, but an increase in some other conditions like kidney ...
eDepartment of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea fDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results